Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation

Journal of Heart and Lung Transplantation

Volumn 29, Issue 3, 2010, Pages 278-285

  Allen, Jeremiah G ^a   Weiss, Eric S ^a   Schaffer, Justin M ^a   Patel, Nishant D ^a   Ullrich, Susan L ^a   Russell, Stuart D ^b   Shah, Ashish S ^a   Conte, John V ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

functional status; LVAD; quality of life (QOL)

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DATA BASE; DEFIBRILLATOR; FEMALE; FUNCTIONAL STATUS; HEALTH SURVEY; HEART ASSIST DEVICE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; IMPLANTATION; INTESTINE ISCHEMIA; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; QUALITY OF LIFE; REOPERATION; SURVIVAL RATE;

ADULT; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HEART-ASSIST DEVICES; HUMANS; MALE; METABOLIC EQUIVALENT; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SURVIVORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; WALKING;

EID: 77349084865     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.07.017     Document Type: Article

References (43)

1. American Heart Association. Heart disease and stroke statistics, 2009 update (2009), American Heart Association, Dallas, TX
2. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316 (1987) 1429-1435
3. Levy D., Kenchaiah S., Larson M.G., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347 (2002) 1397-1402
4. Roger V.L., Weston S.A., Redfield M.M., et al. Trends in heart failure incidence and survival in a community-based population. JAMA 292 (2004) 344-350
5. Feller E.D., Sorensen E.N., Haddad M., et al. Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients. Ann Thorac Surg 83 (2007) 1082-1088
6. John R., Kamdar F., Liao K., et al. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 86 (2008) 1227-1234
7. Garatti A., Bruschi G., Colombo T., et al. Clinical outcome and bridge to transplant rate of left ventricular assist device recipient patients: comparison between continuous-flow and pulsatile-flow devices. Eur J Cardiothorac Surg 34 (2008) 275-280
8. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
9. Park S.J., Tector A., Piccioni W., et al. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg 129 (2005) 9-17
10. Rogers J.G., Butler J., Lansman S.L., et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol 50 (2007) 741-747
11. Oz M.C., Gelijns A.C., Miller L., et al. Left ventricular assist devices as permanent heart failure therapy: the price of progress. Ann Surg 238 (2003) 577-583
12. Lietz K., Long J.W., Kfoury A.G., et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116 (2007) 497-505
13. Clegg A.J., Scott D.A., Loveman E., et al. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation. Health Technol Assess (Winchester, England) 9 (2005) 1-132
14. Grady K.L., Meyer P., Mattea A., et al. Improvement in quality of life outcomes 2 weeks after left ventricular assist device implantation. J Heart Lung Transplant 20 (2001) 657-669
15. Grady K.L., Meyer P.M., Mattea A., et al. Change in quality of life from before to after discharge following left ventricular assist device implantation. J Heart Lung Transplant 22 (2003) 322-333
16. Miller L.W., Pagani F.D., Russell S.D., et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357 (2007) 885-896
17. Pagani F.D., Miller L.W., Russell S.D., et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 54 (2009) 312-321
18. Grady K.L., Meyer P.M., Dressler D., et al. Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation. Ann Thorac Surg 77 (2004) 1321-1327
19. Wray J., Hallas C.N., and Banner N.R. Quality of life and psychological well-being during and after left ventricular assist device support. Clin Transplant 21 (2007) 622-627
20. Rector T.S., and Cohn J.N. Assessment of patient outcome with the Minnesota Living with Heart Failure Questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J 124 (1992) 1017-1025
21. Rector T.S. Minnesota Living with Heart Failure Questionnaire (2005). www.mlhfq.org (accessed April 1, 2009)
22. MacIver J., Rao V., Delgado D.H., et al. Choices: a study of preferences for end-of-life treatments in patients with advanced heart failure. J Heart Lung Transplant 27 (2008) 1002-1007
23. Rector T.S., Kubo S.H., and Cohn J.N. Validity of the Minnesota Living with Heart Failure Questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol 71 (1993) 1106-1107
24. Guyatt G.H., Sullivan M.J., Thompson P.J., et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 132 (1985) 919-923
25. Enright P.L. The six-minute walk test. Respir Care 48 (2003) 783-785
26. Enright P.L., and Sherrill D.L. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 158 (1998) 1384-1387
27. ATS statement. Guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 (2002) 111-117
28. Demers C., McKelvie R.S., Negassa A., et al. Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure. Am Heart J 142 (2001) 698-703
29. Alahdab M.T., Mansour I.N., Napan S., et al. Six minute walk test predicts long-term all-cause mortality and heart failure rehospitalization in African-American patients hospitalized with acute decompensated heart failure. J Card Fail 15 (2009) 130-135
30. Ainsworth B.E., Haskell W.L., Leon A.S., et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 25 (1993) 71-80
31. Hernandez A.F., Shea A.M., Milano C.A., et al. Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. JAMA 300 (2008) 2398-2406
32. Hutchinson J., Scott D.A., Clegg A.J., et al. Cost-effectiveness of left ventricular-assist devices in end-stage heart failure. Exp Rev Cardiovasc Ther 6 (2008) 175-185
33. Bittner V., Weiner D.H., Yusuf S., et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA 270 (1993) 1702-1707
34. Cahalin L.P., Mathier M.A., Semigran M.J., et al. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 110 (1996) 325-332
35. Peeters P., and Mets T. The 6-minute walk as an appropriate exercise test in elderly patients with chronic heart failure. J Gerontol 51 (1996) M147-M151
36. Maurer M.S., Cuddihy P., Weisenberg J., et al. The prevalence and impact of anergia (lack of energy) in subjects with heart failure and its associations with actigraphy. J Card Fail 15 (2009) 145-151
37. Balashov K., Feldman D.E., Savard S., et al. Percent predicted value for the 6-minute walk test: using norm-referenced equations to characterize severity in persons with CHF. J Card Fail 14 (2008) 75-81
38. Rector T.S., Tschumperlin L.K., Kubo S.H., et al. Use of the Living with Heart Failure Questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail 1 (1995) 201-206
39. Kubo S.H., Schulman S., Starling R.C., et al. Development and validation of a patient questionnaire to determine New York Heart Association classification. J Card Fail 10 (2004) 228-235
40. Helman D.N., and Oz M.C. Developing a comprehensive mechanical support program. J Card Surg 16 (2001) 203-208
41. John R. Current axial-flow devices-the HeartMate II and Jarvik 2000 left ventricular assist devices. Sem Thorac Cardiovasc Surg 20 (2008) 264-272
42. Kamdar F., Boyle A., Liao K., et al. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. J Heart Lung Transplant 28 (2009) 352-359
43. Zierer A., Melby S.J., Voeller R.K., et al. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg 84 (2007) 515-520